CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 272 | -90.9% | 0.00% | – |
| Q2 2021 | $8,000 | +166.7% | 3,000 | +200.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 1,000 | +371.7% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 212 | +0.5% | 0.00% | – |
| Q2 2020 | $1,000 | – | 211 | +0.5% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 210 | -17.0% | 0.00% | – |
| Q3 2018 | $2,000 | – | 253 | +1586.7% | 0.00% | – |
| Q2 2018 | $0 | – | 15 | +400.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 3 | -96.4% | 0.00% | – |
| Q4 2017 | $1,000 | -90.9% | 84 | -88.3% | 0.00% | – |
| Q3 2017 | $11,000 | – | 720 | +2566.7% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 27 | -76.9% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 117 | -25.9% | 0.00% | – |
| Q4 2016 | $2,000 | – | 158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
| Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
| CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
| Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
| Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
| Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
| BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
| VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |